Kontafarma China Holdings Limited (01312) released its monthly return on 2 February 2026, reporting no changes in the number of authorized or issued shares as of 31 January 2026.

The total authorized share capital remains at 100,000,000,000 ordinary shares at a par value of HKD 0.002, representing HKD 200,000,000. The issued share capital stands at 5,588,571,777 ordinary shares, with zero treasury shares, showing no change compared to the previous month.

The company confirmed that it satisfies the public float requirement of 25% for its listed ordinary shares, with no share options, warrants, or other convertible securities in issue during the reporting period.